Craig Conoscenti

1.4k total citations
40 papers, 792 citations indexed

About

Craig Conoscenti is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology. According to data from OpenAlex, Craig Conoscenti has authored 40 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 21 papers in Physiology and 6 papers in Rheumatology. Recurrent topics in Craig Conoscenti's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (31 papers), Sarcoidosis and Beryllium Toxicity Research (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Craig Conoscenti is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (31 papers), Sarcoidosis and Beryllium Toxicity Research (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Craig Conoscenti collaborates with scholars based in United States, Germany and Canada. Craig Conoscenti's co-authors include Kevin K. Brown, Dirk Eßer, Jeffrey J. Swigris, Scott M. Palmer, Fernando J. Martínez, Anastasia E. Raczek, Amy Phillips, Frederic D. Seifer, Clare E. Hawkins and Tammy G. Curtice and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

Craig Conoscenti

34 papers receiving 774 citations

Peers

Craig Conoscenti

PRM

PHYSI

PHEOH

EPIDE

RHEUM

A. Cavaillès France

Alida Benfante Italy

David Hotchkin United States

Piotr Boros Poland

Jens Dollerup Denmark

Mark Britton United Kingdom

Claire Maden United Kingdom

Denise King United Kingdom

Rosanna Niniano Italy

Yuji Oba United States

A. Cavaillès France

Craig Conoscenti

574 ×0.8

PRM

174 ×0.5

PHYSI

38 ×0.5

PHEOH

78 ×1.3

EPIDE

9 ×0.2

RHEUM

Citations per year, relative to Craig Conoscenti Craig Conoscenti (= 1×) peers A. Cavaillès

Countries citing papers authored by Craig Conoscenti

Since Specialization

Citations

This map shows the geographic impact of Craig Conoscenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Conoscenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Conoscenti more than expected).

Fields of papers citing papers by Craig Conoscenti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Conoscenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Conoscenti. The network helps show where Craig Conoscenti may publish in the future.

Co-authorship network of co-authors of Craig Conoscenti

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Conoscenti. A scholar is included among the top collaborators of Craig Conoscenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Conoscenti. Craig Conoscenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corte, Tamera J., Deepthi Nair, Hao Bao, et al.. (2025). Long-term Safety and Efficacy Data With Inhaled Pirfenidone (AP01) in the Atlas Open-label Extension Study Up to 240 Weeks. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2906–A2906.

Swaminathan, Aparna, Timothy P. Whelan, Megan L. Neely, et al.. (2024). Association of Quantitative Lung Fibrosis (QLF) Score With the Severity and Progression of Progressive Pulmonary Fibrosis (PPF). A5085–A5085.

Ji, Xinge, Pratik Pimple, Amy L. Olson, et al.. (2024). Proportion and predictors of FVC decline in patients with interstitial lung disease. Respiratory Medicine. 227. 107656–107656.

Aggarwal, Rohit, Chester V. Oddis, Siamak Moghadam‐Kia, et al.. (2024). Design of a randomised controlled hybrid trial of nintedanib in patients with progressive myositis-associated interstitial lung disease. BMC Pulmonary Medicine. 24(1). 544–544. 4 indexed citations

Singer, David, et al.. (2023). Impact of chronic fibrosing interstitial lung disease on healthcare use: association between fvc decline and inpatient hospitalization. BMC Pulmonary Medicine. 23(1). 337–337. 3 indexed citations

Andrade, João A. de, Megan L. Neely, Anne S. Hellkamp, et al.. (2023). Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis. Clinical Therapeutics. 45(4). 306–315. 16 indexed citations

Singer, David, Lindsay G.S. Bengtson, Craig Conoscenti, et al.. (2022). Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States. Annals of the American Thoracic Society. 19(7). 1112–1121. 7 indexed citations

Case, Amy Hajari, Anne S. Hellkamp, Megan L. Neely, et al.. (2020). Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry. Annals of the American Thoracic Society. 17(6). 699–705. 18 indexed citations

Salisbury, Margaret L., Craig Conoscenti, Daniel A. Culver, et al.. (2020). Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry. Annals of the American Thoracic Society. 17(11). 1413–1423. 33 indexed citations

10.

Lancaster, Lisa, Jonathan Goldin, Matthias Trampisch, et al.. (2020). Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis. The Open Respiratory Medicine Journal. 14(1). 22–31. 30 indexed citations

11.

Bender, Shaun, Craig Conoscenti, Linda Davidson‐Ray, et al.. (2020). Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry. CHEST Journal. 157(6). 1522–1530. 17 indexed citations

12.

Snyder, Laurie D., Megan L. Neely, Anne S. Hellkamp, et al.. (2019). Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry. Respiratory Research. 20(1). 105–105. 50 indexed citations

13.

Durheim, Michael T., Jennifer Judy, Shaun Bender, et al.. (2019). In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study. Lung. 197(6). 699–707. 21 indexed citations

14.

Flaherty, Kevin, Martin Kolb, Carlo Vancheri, et al.. (2018). Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis. European Respiratory Journal. 52(2). 1702593–1702593. 32 indexed citations

15.

O’Brien, Emily C., Michael T. Durheim, Victoria Gamerman, et al.. (2016). Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry. BMJ Open Respiratory Research. 3(1). e000108–e000108. 38 indexed citations

16.

White, Eric S., Kevin M. Brown, Harold R. Collard, et al.. (2014). Open-Access Biorepository for Idiopathic Pulmonary Fibrosis. The Way Forward. Annals of the American Thoracic Society. 11(8). 1171–1175. 10 indexed citations

17.

Criner, Gerard J., et al.. (2008). Efficacy of Tiotropium Inhalation Powder in African-American Patients with Chronic Obstructive Pulmonary Disease. COPD Journal of Chronic Obstructive Pulmonary Disease. 5(1). 35–41. 21 indexed citations

18.

Gelb, Arthur F., et al.. (2008). Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. Pulmonary Pharmacology & Therapeutics. 21(4). 630–636. 15 indexed citations

19.

Covelli, Henry D., et al.. (2005). Absence of Electrocardiographic Findings and Improved Function with Once‐Daily Tiotropium in Patients with Chronic Obstructive Pulmonary Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(12). 1708–1718. 46 indexed citations

20.

Casaburi, Richard & Craig Conoscenti. (2004). Lung function improvements with once-daily tiotropium in chronic obstructive pulmonary disease. PubMed. 117(12). 33–40. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact